Insider · CIK 0001328625
Edward T Mathers
directorowner
Files at TRVI (Trevi Therapeutics, Inc.), OKUR (OnKure Therapeutics, Inc.), RYTM (RHYTHM PHARMACEUTICALS, INC.), MBX (MBX Biosciences, Inc.), SNTI (Senti Biosciences, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 25, 2025 | SNTI Senti Biosciences, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +21,950 | $0.00 | $0 | 21,950 | Jun 27, 2025 |
| Jun 24, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | AGrant or award Stock Option (right to buy)derivative | +7,037 | $0.00 | $0 | 7,037 | Jun 26, 2025 |
| Jun 24, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | AGrant or award Restricted Stock Unitsderivative | +4,712 | $0.00 | $0 | 4,712 | Jun 26, 2025 |
| Jun 18, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | MOption exercise Common Stock | +4,000 | - | - | 7,000 | Jun 23, 2025 |
| Jun 18, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | MOption exercise Restricted Stock Unitsderivative | -4,000 | $0.00 | $0 | 0 | Jun 23, 2025 |
| Jun 11, 2025 | TRVI Trevi Therapeutics, Inc. | AGrant or award Nonstatutory Stock Option (right to buy)derivative | +45,000 | $0.00 | $0 | 45,000 | Jun 13, 2025 |
| Jun 5, 2025 | MBX MBX Biosciences, Inc. | AGrant or award Stock option (right to buy)derivative | +16,000 | $0.00 | $0 | 16,000 | Jun 6, 2025 |
| May 28, 2025 | OKUR OnKure Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +7,650 | $0.00 | $0 | 7,650 | May 30, 2025 |
| Mar 31, 2025 | OKUR OnKure Therapeutics, Inc. | AGrant or award Class A Common Stock | +2,580 | $0.00 | $0 | 2,580 | Apr 2, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.